URGN
$33.91-0.38%
UroGen Pharma Ltd.Stock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.004% of ONEQRussell 3000 · 0.003% of IWV
UroGen Pharma Ltd. monthly returns
UroGen Pharma Ltd. has averaged 3.11% per month, positive in 46% of months. Month-by-month returns for UroGen Pharma Ltd. (URGN) below, through October 27, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+3.1%
106 months
Best month
+223.1%
Jun 2025
Worst month
-63.6%
May 2025
Positive months
46%
of all months
UroGen Pharma Ltd. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -16.5% | |
| Sep 2026 | -5.7% | |
| Aug 2026 | +12.7% | |
| Jul 2026 | +3.9% | |
| Jun 2026 | +30.8% | |
| May 2026 | +18.0% | |
| Apr 2026 | +32.5% | |
| Mar 2026 | -17.1% | |
| Feb 2026 | +10.7% | |
| Jan 2026 | -16.3% | |
| Dec 2025 | -18.7% | |
| Nov 2025 | +40.7% | |
| Oct 2025 | +2.6% | |
| Sep 2025 | +2.6% | |
| Aug 2025 | +2.0% | |
| Jul 2025 | +39.1% | |
| Jun 2025 | +223.1% | |
| May 2025 | -63.6% | |
| Apr 2025 | +5.2% | |
| Mar 2025 | +16.9% | |
| Feb 2025 | -14.1% | |
| Jan 2025 | +3.4% | |
| Dec 2024 | -16.1% | |
| Nov 2024 | +3.6% | |
| Oct 2024 | -3.5% | |
| Sep 2024 | -8.7% | |
| Aug 2024 | -15.4% | |
| Jul 2024 | -2.0% | |
| Jun 2024 | +26.2% | |
| May 2024 | -3.8% | |
| Apr 2024 | -7.9% | |
| Mar 2024 | -18.2% | |
| Feb 2024 | +16.8% | |
| Jan 2024 | +4.7% | |
| Dec 2023 | +13.7% | |
| Nov 2023 | +17.7% | |
| Oct 2023 | -20.0% | |
| Sep 2023 | -19.9% | |
| Aug 2023 | -19.3% | |
| Jul 2023 | +109.3% | |
| Jun 2023 | +4.5% | |
| May 2023 | -14.6% | |
| Apr 2023 | +25.4% | |
| Mar 2023 | -10.3% | |
| Feb 2023 | -0.9% | |
| Jan 2023 | +17.1% | |
| Dec 2022 | +3.5% | |
| Nov 2022 | -27.7% | |
| Oct 2022 | +42.4% | |
| Sep 2022 | +11.7% | |
| Aug 2022 | -5.0% | |
| Jul 2022 | -4.3% | |
| Jun 2022 | +53.9% | |
| May 2022 | -24.6% | |
| Apr 2022 | -18.9% | |
| Mar 2022 | +45.2% | |
| Feb 2022 | -22.3% | |
| Jan 2022 | -18.8% | |
| Dec 2021 | -21.3% | |
| Nov 2021 | -29.7% | |
| Oct 2021 | +2.3% | |
| Sep 2021 | -4.5% | |
| Aug 2021 | +13.7% | |
| Jul 2021 | +1.5% | |
| Jun 2021 | -13.3% | |
| May 2021 | -9.4% | |
| Apr 2021 | -0.2% | |
| Mar 2021 | +2.3% | |
| Feb 2021 | -13.7% | |
| Jan 2021 | +22.5% | |
| Dec 2020 | -13.2% | |
| Nov 2020 | -7.9% | |
| Oct 2020 | +16.7% | |
| Sep 2020 | -23.1% | |
| Aug 2020 | +13.6% | |
| Jul 2020 | -15.4% | |
| Jun 2020 | +11.3% | |
| May 2020 | +5.7% | |
| Apr 2020 | +24.5% | |
| Mar 2020 | -34.6% | |
| Feb 2020 | -7.3% | |
| Jan 2020 | -11.9% | |
| Dec 2019 | +5.5% | |
| Nov 2019 | +39.8% | |
| Oct 2019 | -5.0% | |
| Sep 2019 | -29.8% | |
| Aug 2019 | -0.4% | |
| Jul 2019 | -5.1% | |
| Jun 2019 | +5.5% | |
| May 2019 | -5.3% | |
| Apr 2019 | -2.7% | |
| Mar 2019 | -4.0% | |
| Feb 2019 | -7.1% | |
| Jan 2019 | -3.8% | |
| Dec 2018 | -12.2% | |
| Nov 2018 | +22.9% | |
| Oct 2018 | -15.5% | |
| Sep 2018 | -2.3% | |
| Aug 2018 | +6.9% | |
| Jul 2018 | -9.2% | |
| Jun 2018 | -17.2% | |
| May 2018 | +7.3% | |
| Apr 2018 | +12.7% | |
| Mar 2018 | -5.6% | |
| Feb 2018 | +7.2% | |
| Jan 2018 | +32.0% | |
| Dec 2017 | -7.8% | |
| Nov 2017 | +27.2% | |
| Oct 2017 | +0.7% | |
| Sep 2017 | +32.2% | |
| Aug 2017 | +31.3% | |
| Jul 2017 | +0.6% | |
| Jun 2017 | +1.2% |
Monthly total return (since Nov 2021)#
-200%-100%0%100%200%
Nov 2021-30%
Dec 2021-21%
Jan 2022-19%2022
Feb 2022-22%
Mar 2022+45%
Apr 2022-19%
May 2022-25%
Jun 2022+54%
Jul 2022-4.3%
Aug 2022-5.0%
Sep 2022+12%
Oct 2022+42%
Nov 2022-28%
Dec 2022+3.5%
Jan 2023+17%2023
Feb 2023-0.87%
Mar 2023-10%
Apr 2023+25%
May 2023-15%
Jun 2023+4.5%
Jul 2023+109%
Aug 2023-19%
Sep 2023-20%
Oct 2023-20%
Nov 2023+18%
Dec 2023+14%
Jan 2024+4.7%2024
Feb 2024+17%
Mar 2024-18%
Apr 2024-7.9%
May 2024-3.8%
Jun 2024+26%
Jul 2024-2.0%
Aug 2024-15%
Sep 2024-8.7%
Oct 2024-3.5%
Nov 2024+3.6%
Dec 2024-16%
Jan 2025+3.4%2025
Feb 2025-14%
Mar 2025+17%
Apr 2025+5.2%
May 2025-64%
Jun 2025+223%
Jul 2025+39%
Aug 2025+2.0%
Sep 2025+2.6%
Oct 2025+2.6%
Nov 2025+41%
Dec 2025-19%
Jan 2026-16%2026
Feb 2026+11%
Mar 2026-17%
Apr 2026+33%
May 2026+18%
Jun 2026+31%
Jul 2026+3.9%
Aug 2026+13%
Sep 2026-5.7%
Oct 2026-17%
UroGen Pharma Ltd. returns by calendar month#
Every month of every year since 2018, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -16.54% — 8th of 9 Octobers since 2018 at the last close; the average October returned +2.5%.
| Month | −225%0+225% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +3.2% | +3.4% | 56% | +32.0% 2018 | -18.8% 2022 | |
| Feb | -3.4% | -7.1% | 33% | +16.8% 2024 | -22.3% 2022 | |
| Mar | -2.8% | -5.6% | 33% | +45.2% 2022 | -34.6% 2020 | |
| Apr | +7.9% | +5.2% | 56% | +32.5% 2026 | -18.9% 2022 | |
| May | -10.0% | -5.3% | 33% | +18.0% 2026 | -63.6% 2025 | |
| Jun | +36.1% | +11.3% | 78% | +223.1% 2025 | -17.2% 2018 | |
| Jul | +13.1% | -2.0% | 44% | +109.3% 2023 | -15.4% 2020 | |
| Aug | +1.0% | +2.0% | 56% | +13.7% 2021 | -19.3% 2023 | |
| Sep | -8.9% | -5.7% | 22% | +11.7% 2022 | -29.8% 2019 | |
| Oct | +2.5% | -0.6% | 50% | +42.4% 2022 | -20.0% 2023 | |
| Nov | +7.4% | +10.6% | 63% | +40.7% 2025 | -29.7% 2021 | |
| Dec | -7.4% | -12.7% | 38% | +13.7% 2023 | -21.3% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from URGN's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is UroGen Pharma Ltd.'s average monthly return?
- UroGen Pharma Ltd. (URGN) has averaged about 3.11% per month, positive in roughly 46% of months. The best month was Jun 2025 (+223.1%) and the worst was May 2025 (-63.6%).
More on UroGen Pharma Ltd.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100